The Sudden, Excruciating Joint Pain
You go to bed feeling fine and wake at 3am with your big toe on fire. The pain is so intense that even the weight of a bedsheet is unbearable. The joint is swollen, red, hot, and exquisitely tender. This is a classic gout attack – one of the most painful conditions in medicine, and one that is increasingly common.
At our practice in Zürich Seefeld, I treat gout as a metabolic condition, not just a painful joint. Because gout is far more than occasional attacks – it is a marker of metabolic dysfunction that, if left unaddressed, increases cardiovascular and kidney disease risk.
What Causes Gout?
Gout occurs when uric acid levels in the blood are chronically elevated (hyperuricaemia), leading to the formation and deposition of monosodium urate crystals in joints and surrounding tissues. These crystals trigger an intense inflammatory response – the gout attack.
Overproduction of uric acid: Purine-rich diets (red meat, organ meats, certain seafood), alcohol (particularly beer), fructose-sweetened beverages, and genetic factors.
Underexcretion of uric acid: The more common mechanism. The kidneys excrete approximately two-thirds of uric acid, and impaired renal excretion is the primary driver in most patients. Causes include genetic variations in urate transporters, kidney disease, certain medications (diuretics, low-dose aspirin), insulin resistance, and dehydration.
Metabolic syndrome: Gout is strongly associated with insulin resistance, obesity, hypertension, and dyslipidaemia. Elevated insulin reduces renal uric acid excretion, directly linking metabolic health to gout risk.
Beyond the Big Toe
While the first metatarsophalangeal joint (big toe) is the classic location, gout can affect any joint – ankles, knees, wrists, fingers, and elbows. Chronic gout can lead to tophi (visible uric acid deposits under the skin), joint destruction, kidney stones, and chronic kidney disease.
Our Diagnostic Approach
Diagnosis is based on clinical presentation, uric acid levels (though these can be misleadingly normal during an acute attack), inflammatory markers, and ideally joint aspiration showing urate crystals under polarised microscopy. I also assess for metabolic syndrome (fasting glucose, insulin, lipids, blood pressure), kidney function, and cardiovascular risk – because gout rarely exists in isolation.
What We Do: Treating the Attack and the Cause
Acute attack management: NSAIDs, colchicine, or corticosteroids for rapid pain relief. Early treatment shortens attacks significantly.
Urate-lowering therapy: For patients with recurrent attacks, tophi, or kidney stones, medications like allopurinol or febuxostat reduce uric acid levels and prevent crystal formation. The target is below 360 µmol/L (or below 300 for tophaceous gout).
Metabolic optimisation: Addressing insulin resistance, weight management, and reducing fructose and alcohol intake. Improving metabolic health naturally reduces uric acid levels.
Dietary guidance: Nuanced advice beyond “avoid purines.” Reducing sugar-sweetened beverages and beer has more impact than avoiding moderate amounts of meat or seafood. Cherries and vitamin C have modest evidence for reducing uric acid.
Cardiovascular risk management: Because gout patients have significantly elevated cardiovascular risk, I address all modifiable risk factors comprehensively.
Conclusion
Gout is not just a painful joint – it is a metabolic disease that signals broader health risks. Effective management requires treating both the acute attacks and the underlying metabolic dysfunction. If you have had a gout attack or have elevated uric acid, book a consultation at our practice in Zürich Seefeld for comprehensive assessment and management.
